- AboutOpenClose
- TeamOpenClose
- CareersOpenClose
- Investment FocusOpenClose
- Contract Services & Enabling TechnologiesOpenClose
- Biotech & MedtechOpenClose
- Antimicrobial ResistanceOpenClose
- FoundryOpenClose
- PortfolioOpenClose
- MediaOpenClose
Endolytix Closed on Additional Financing with New Investment from the Kineticos AMR Accelerator Fund I October 29, 2024 – Kineticos…
AMR Efforts in Q3 2024 RALEIGH, N.C. | October 24, 2024 – The Kineticos AMR Accelerator Fund I (“KAMRA”) envisions…
The Kineticos AMR Accelerator Fund I Invests in Orthobond Kineticos Strategic Advisor Steve Favaloro will join Orthobond’s Board of Directors…
Kincell Bio Announces New Board Chairman Mark R. Bamforth to Accelerate Company’s Growth and Expansion May 21st 2024 – Kincell Bio,…
EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials, Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowl…
neuro42, a Kineticos Portfolio Company, Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging…
Kineticos and INCATE join forces in supporting AMR innovators December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in…
Kineticos Life Sciences Announces Successful Final Close of approximately $60 Million for Kineticos Disruptor Fund II RALEIGH, N.C. | November…
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…